HIGHLIGHTS
- who: Maaike Y. Kapteijn and colleagues from the Department of Internal Medicine, Leiden University Medical Center, ZA Leiden, The Netherlands have published the paper: Temozolomide and Lomustine Induce Tissue Factor Expression and Procoagulant Activity in Glioblastoma Cells In Vitro, in the Journal: Cancers 2023, 15, 2347. of /2023/
- what: The authors aimed to examine the effect of routinely used chemotherapeutic agents (TMZ) and_(LOM) on TF procoagulant activity and expression in GBM cells in vitro. The authors show that both chemotherapeutic modalities induce TF-mediated procoagulant activity and expression in all GBM cell lines tested . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.